Budget Amount *help |
¥4,290,000 (Direct Cost: ¥3,300,000、Indirect Cost: ¥990,000)
Fiscal Year 2020: ¥1,170,000 (Direct Cost: ¥900,000、Indirect Cost: ¥270,000)
Fiscal Year 2019: ¥1,170,000 (Direct Cost: ¥900,000、Indirect Cost: ¥270,000)
Fiscal Year 2018: ¥1,950,000 (Direct Cost: ¥1,500,000、Indirect Cost: ¥450,000)
|
Outline of Final Research Achievements |
The clinical efficacy of B cell-targeted therapy for autoimmune diseases has gained attention to the antibody-independent functions of B cells, particularly their ability to produce cytokines. In this study we identified novel memory B cell subsets that produce GM-CSF, CXCL9/10, and IFNγ,and elucidated the differentiation induction mechanisms and their roles in the pathogenesis of autoimmune diseases.
|